copyright and Wegovy, two recent advances in the field of weight management, have attracted significant attention for their remarkable results. These medications, both belonging to a class called GLP-1 receptor agonists, work by regulating the body's natural processes to minimize appetite and improve insulin sensitivity. Early clinical trials have